tiprankstipranks
Applied Genetic Technologies (AGTC)
NASDAQ:AGTC
Holding AGTC?
Track your performance easily

Applied Genetic Technologies (AGTC) Income Statement

0 Followers

Applied Genetic Technologies Income Statement

Last quarter (Q ), Applied Genetic Technologies's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, Applied Genetic Technologies's net income was $-18.41M. See Applied Genetic Technologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21Jun 20Jun 19Jun 18
Total Revenue
$ 325.00K$ 325.00K$ 500.00K$ 2.45M$ 41.69M$ 24.19M
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 67.42M$ 66.50M$ 58.95M$ 49.40M$ 46.04M$ 46.57M
Operating Income
$ -67.09M$ -66.17M$ -58.45M$ -46.94M$ -4.35M$ -22.38M
Net Non Operating Interest Income Expense
$ -2.66M$ -2.67M$ -1.51M$ -11.00K--
Other Income Expense
$ -241.00K$ 99.00K$ 116.00K$ 1.19M$ 2.46M$ 1.18M
Pretax Income
$ -70.00M$ -68.75M$ -59.84M$ -45.76M$ -1.90M$ -21.21M
Tax Provision
-$ 0.00$ -2.11M$ 83.00K$ 76.00K$ 72.00K
Earnings From Equity Interest Net Of Tax
$ -237.00K$ -193.00K$ -96.00K$ -47.00K$ -35.00K$ -20.00K
Net Income Common Stockholders
$ -70.23M$ -68.94M$ -57.83M$ -45.89M$ -2.01M$ -21.30M
Basic EPS
$ -1.42$ -1.53$ -1.77$ -2.17$ -0.11$ -1.18
Diluted EPS
$ -1.42$ -1.53$ -1.77$ -2.17$ -0.11$ -1.18
Basic Average Shares
$ 202.22M$ 45.03M$ 32.76M$ 21.10M$ 18.16M$ 18.11M
Diluted Average Shares
$ 202.22M$ 45.03M$ 32.76M$ 21.10M$ 18.16M$ 18.11M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 67.42M$ 66.50M$ 58.95M$ 49.40M$ 46.04M$ 46.57M
Net Income From Continuing And Discontinued Operation
$ -70.23M$ -68.94M$ -57.83M$ -45.89M$ -2.01M$ -21.30M
Normalized Income
$ -70.32M$ -69.04M$ -57.94M$ -47.08M$ -3.47M$ -22.60M
Interest Expense
$ 2.66M$ 2.67M$ 1.51M$ 11.00K--
EBIT
$ -67.33M$ -66.08M$ -58.34M$ -45.75M$ -4.35M$ -22.38M
EBITDA
$ -65.81M$ -64.56M$ -56.88M$ -44.42M$ -3.08M$ -21.21M
Currency in USD

Applied Genetic Technologies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis